| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,335 | $40.08 | $53,500.94 | -0.1% | +66.4% | +199.3% | |
| Oct 20, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 164 | $3.44 | $564.16 | -0.9% | +2.2% | +1782.4% | |
| Oct 17, 2023 | XGN Exagen Inc. | Aballi John64 | President And CEO | Sell | 33,819 | $1.75 | $59,017.54 | -7.5% | +21.1% | +67.3% | |
| Oct 17, 2023 | WGS Genedx Holdings Corp. | Ryan Jason65 | Executive Chairman | Sell | 42 | $3.19 | $133.98 | -0.7% | +0.9% | +1741.8% | |
| Oct 12, 2023 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 13,007 | $66.49 | $864,835.43 | -25.5% | +8.5% | +9.9% | |
| Oct 3, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 85 | $3.56 | $302.66 | -0.5% | -27.1% | +1157.7% | |
| Oct 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,818 | $6.91 | $19,483.37 | -0.6% | +74.1% | +350.8% | |
| Sep 29, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,291 | $45.91 | $105,185.39 | -1.7% | +40.2% | +184.1% | |
| Sep 28, 2023 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Buy | 3 | $111.09 | $287.72 | - | +24.8% | +32.2% | |
| Sep 28, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 732 | $45.82 | $33,537.46 | -0.4% | +35.1% | +177.4% | |
| Sep 28, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,448 | $46.06 | $250,908.87 | -0.6% | +35.1% | +177.4% | |
| Sep 28, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,617 | $45.82 | $119,901.00 | -1.2% | +35.1% | +177.4% | |
| Sep 28, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 13,130,147 | $0.17 | $2,271,957.14 | -64.7% | - | - | |
| Sep 26, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 5,392,920 | $0.20 | $1,082,359.04 | -29.1% | - | - | |
| Sep 25, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 250,000 | $0.25 | $62,500.00 | -1.3% | - | - | |
| Sep 22, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 5,079,344 | $0.26 | $1,314,534.23 | -21.3% | - | - | |
| Sep 21, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 6,338,211 | $0.30 | $1,904,632.41 | -21.0% | - | - | |
| Sep 21, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 127,308 | $250.05 | $31,833,495.29 | -1.1% | +25.9% | +51.9% | |
| Sep 21, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 127,308 | $250.05 | $31,833,495.29 | -1.1% | +25.9% | +51.9% | |
| Sep 20, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 7,753,710 | $0.31 | $2,408,302.33 | -20.4% | - | - | |
| Sep 19, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 10,401,466 | $0.37 | $3,806,936.56 | -21.5% | - | - | |
| Sep 19, 2023 | IQV Iqvia Holdings Inc. | Panagos Constantinos | See Remarks | Sell | 27,317 | $208.67 | $5,700,339.59 | -36.6% | +8.2% | +16.2% | |
| Sep 19, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 190,764 | $263.89 | $50,339,893.74 | -1.5% | +17.8% | +41.3% | |
| Sep 19, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 190,764 | $263.89 | $50,339,893.74 | -1.5% | +17.8% | +41.3% | |
| Sep 18, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,742 | $4.16 | $11,409.46 | -14.0% | -53.9% | +830.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.